Abionyx Pharma SA
F:609
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abionyx Pharma SA
F:609
|
FR |
|
Pact Group Holdings Ltd
ASX:PGH
|
AU |
Multiples-Based Value
The Multiples-Based Value for
Abionyx Pharma SA (609) under the Base Case is 0.905 EUR.
Compared with the current market price of 3.315 EUR, the stock appears
Overvalued by 73% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.